e-Article – 부산대학교 도서관

e-Article

replayBack to search results

searchSearch screen

Etrolizumab as induction and maintenance therapy in patients with moderately to severely active Crohn's disease (BERGAMOT): a randomised, placebo-controlled, double-blind, phase 3 trial

Document Type

Article

Author

Sandborn, William J ; Panés, Julian ; Danese, Silvio; Sharafali, Zaineb; Hassanali, Azra; Jacob-Moffatt, Rhian; Eden, Christopher; Daperno, Marco; Valentine, John F; Laharie, David; Baía, Carolina; Atreya, Raja; Panaccione, Remo; Rydzewska, Grazyna; Aguilar, Humberto; Vermeire, Séverine

Source

In The Lancet Gastroenterology & Hepatology January 2023 8(1):43-55

Subject

Primary Research
Articles

Language

ISSN

2468-1253

Online Access

Full Text (ScienceDirect 종량제) Web of Science JCR 저널정보 Scopus Find it@PNU

이메일